Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - MEDICINES CO /DE | y80305exv32w2.htm |
| 10-Q - FORM 10-Q - MEDICINES CO /DE | y80305e10vq.htm |
| EX-31.2 - EX-31.2 - MEDICINES CO /DE | y80305exv31w2.htm |
| EX-10.1 - EX-10.1 - MEDICINES CO /DE | y80305exv10w1.htm |
| EX-31.1 - EX-31.1 - MEDICINES CO /DE | y80305exv31w1.htm |
| EX-10.2 - EX-10.2 - MEDICINES CO /DE | y80305exv10w2.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of The Medicines Company (the “Company”)
for the period ended September 30, 2009 as filed with the Securities and Exchange Commission on the
date hereof (the “Report”), I, Clive A. Meanwell, Chairman and Chief Executive Officer of the
Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
| By: | /s/ Clive A. Meanwell | |||
| Clive A. Meanwell | ||||
| Chairman and Chief Executive Officer | ||||
Dated: November 9, 2009